Polypore mushroom mycelia as an adjunct to COVID-19 vaccination: a randomized clinical trial

By afschroeder • February 1, 2026

Saxe G, Smith CN, Golshan S, Shekhtman T, Bair ZJ, Beathard C, Davis RA, MacElhern L, Shubov A, Slater D, Kao LK, Senowitz P, Wilson S. Polypore mushroom mycelia as an adjunct to COVID-19 vaccination: a randomized clinical trial. BMC Immunol. 2026 Jan 31. doi: 10.1186/s12865-026-00809-9. Epub ahead of print. PMID: 41620671.

Tags: Adjunct, Antibodies, Bird flu, Covid, fungi, General Internal Medicine, Mushroom, mycelium, Primary Care, Publications, SARS-CoV-2, side effects, vaccine

Sex does not modify prediction of asthma attacks by clinical risk factors and Type-2 biomarkers

Riemann S, Meulmeester FL, Mailhot-Larouche S, Ramakrishnan S, Wechsler ME, Corren J, Diver SE, Brightling CE, Castro M, Hanania NA, Jackson DJ, Martin N, Laugerud[...]

Rheumatoid arthritis in crisis: investigating the impact of stress on RA flares during the COVID-19 pandemic

Morris NT, Woodworth T, Pham A, Elashoff DA, Brook J, Furst DE, Ranganath VK. Rheumatoid arthritis in crisis: investigating the impact of stress on RA[...]

First Reported Case of Capnocytophaga cynodegmi Infective Endocarditis: A Diagnostic Odyssey

Tran LNB, Zhuo R, Singha M, Sekhon H, Yang S, Fishbein GA, Tymchuk C, Allyn PR. First Reported Case of Capnocytophaga cynodegmi Infective Endocarditis: A[...]